| Fiscal period | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|
| Period End Date | 5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | 5/31/2018 | 5/31/2017 | 5/31/2016 | 5/31/2015 |
|---|
| Sales | 303.91 | 338.75 | 316.22 | 291.01 | 264.16 | 270.63 | 344.29 | 349.64 | 353.89 | 356.97 |
| Total Revenues | 303.91 | 338.75 | 316.22 | 291.01 | 264.16 | 270.63 | 344.29 | 349.64 | 353.89 | 356.97 |
| Cost of sales | 149.22 | 164.51 | 150.49 | 134.22 | 113.89 | 114.63 | 167.41 | 173.47 | 179.57 | 180.09 |
| Gross Profit | 154.70 | 174.25 | 165.73 | 156.79 | 150.27 | 156.00 | 176.88 | 176.17 | 174.32 | 176.89 |
| Goodwill impairment | 159.48 | 14.55 | -- | -- | 158.58 | -- | -- | -- | -- | -- |
| Amortization of intangibles | 13.05 | 18.79 | 19.46 | 18.14 | 18.12 | 17.06 | 16.64 | 17.30 | 17.96 | 17.91 |
| Research and development | 31.51 | 29.88 | 30.74 | 36.39 | 29.68 | 28.26 | 25.46 | 25.27 | 25.05 | 26.93 |
| General and Administrative | 41.16 | 40.00 | 38.45 | 35.92 | 37.87 | 34.90 | 31.27 | 31.41 | 29.60 | 29.87 |
| Sales and marketing | 102.82 | 104.25 | 95.30 | 81.31 | 78.63 | 76.83 | 77.28 | 78.82 | 84.72 | 80.62 |
| Restructuring and other costs, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Acquisition and other non-recurring | 53.18 | 15.63 | 9.04 | 20.23 | 6.01 | 15.13 | 15.43 | 27.51 | 12.59 | 26.60 |
| Litigation provisions, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Change in fair value of contingent consideration | (0.43) | (2.32) | (1.21) | (0.09) | 11.53 | 6.78 | (0.25) | 15.26 | (0.95) | 8.20 |
| Other non recurring items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gain on sale of assets | 54.50 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Medical device excise tax | -- | -- | -- | -- | -- | -- | -- | 1.84 | (2.42) | (4.14) |
| Total Operating Expenses | 401.63 | 225.43 | 194.20 | 192.07 | 317.37 | 165.40 | 166.32 | 163.20 | 173.30 | 177.88 |
| Operating Income (Loss) | (192.44) | (51.18) | (28.47) | (35.28) | (167.10) | (9.40) | 10.56 | 12.97 | 1.02 | (0.99) |
| Interest expense | (1.61) | 2.70 | 0.69 | 0.86 | 0.91 | 5.10 | 3.06 | 2.84 | 3.40 | 3.20 |
| Impairment loss on investment | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest income | -- | -- | -- | -- | -- | -- | -- | -- | 0.01 | 0.00 |
| Other income (loss) | (0.82) | (0.55) | (0.79) | 0.09 | (0.13) | (0.21) | (0.03) | (0.28) | (0.89) | (3.81) |
| Total other (expenses) income, net | 0.80 | (3.26) | (1.48) | (0.77) | (1.04) | (5.31) | (3.09) | (3.12) | (4.27) | (7.01) |
| (Loss) income before income tax provision | (191.64) | (54.44) | (29.95) | (36.05) | (168.14) | (14.70) | 7.47 | 9.85 | (3.25) | (8.00) |
| Deferred | (7.97) | -- | -- | (4.81) | (1.57) | (3.97) | (8.95) | 4.43 | 39.98 | (5.11) |
| Income tax (benefit) provision | (7.29) | (2.00) | (3.40) | (4.50) | (1.35) | (3.56) | (8.87) | 4.84 | 40.34 | (4.73) |
| Current : Federal | -- | -- | -- | -- | -- | -- | (0.15) | -- | 0.03 | (0.24) |
| Current : State and local | 0.32 | 0.13 | 0.12 | 0.10 | 0.10 | 0.13 | 0.15 | 0.14 | 0.10 | 0.21 |
| Current : Non U.S | 0.36 | 0.19 | 0.19 | 0.20 | 0.12 | 0.29 | 0.07 | 0.27 | 0.22 | 0.42 |
| Deferred- U.S | (7.04) | (0.21) | (3.42) | -- | -- | -- | -- | -- | -- | -- |
| Deferred- Non U.S | (0.93) | (2.10) | (0.29) | -- | -- | -- | -- | -- | -- | -- |
| Net income (loss) from continuing operations | -- | -- | -- | (31.55) | (166.79) | (11.15) | -- | -- | -- | -- |
| Income from discontinued operations, net of income tax | -- | -- | -- | -- | -- | 72.49 | -- | -- | -- | -- |
| Net income available to Common Shareholders | (184.35) | (52.44) | (26.55) | (31.55) | (166.79) | 61.34 | 16.34 | 5.01 | (43.59) | (3.27) |
| Basic Earnings (Loss) Per Share From Continuing Operations | -- | -- | -- | (0.82) | (4.39) | (0.30) | -- | -- | -- | -- |
| Basic Earnings per Share from Discontinued Operations | -- | -- | -- | -- | -- | 1.93 | -- | -- | -- | -- |
| Net Earnings Per Share (Basic) | (4.59) | (1.33) | (0.68) | (0.82) | (4.39) | 1.64 | 0.44 | 0.14 | (1.21) | (0.09) |
| Diluted Earnings (Loss) Per Share From Continuing Operations | -- | -- | -- | (0.82) | (4.39) | (0.30) | -- | -- | -- | -- |
| Diluted Earnings per Share from Discontinued Operations | -- | -- | -- | -- | -- | 1.93 | -- | -- | -- | -- |
| Net Earnings Per Share (Diluted) | (4.59) | (1.33) | (0.68) | (0.82) | (4.39) | 1.64 | 0.44 | 0.14 | (1.21) | (0.09) |
| Weighted Average Shares Outstanding (Basic) | 40.18 | 39.48 | 39.01 | 38.34 | 37.96 | 37.49 | 37.08 | 36.62 | 36.16 | 35.68 |
| Weighted Average Shares Outstanding (Diluted) | 40.18 | 39.48 | 39.01 | 38.34 | 37.96 | 37.49 | 37.54 | 36.96 | 36.16 | 35.68 |